Paratek Pharmaceuticals Announces Inclusion of Oral NUZYRA® in China's National Reimbursement Drug List -December 13, 2023 at 08:54 am EST
BOSTON, Dec. 13, 2023 -- Paratek Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of innovative therapies for life-threatening diseases and other...